Michał Wieliński

Languages: Michał Wieliński

Joined GESSEL in 2021. His main area of expertise is capital market law. Michał advises on mergers and acquisitions and corporate disputes. He handles transactions related to raising equity and debt financing through issue of financial instruments. Advises on flotations on the Warsaw Stock Exchange and the NewConnect market. Handles transactions of primary and secondary public offerings (IPOs, SPOs), accelerated book-building processes (ABB), public M&A, tender offers for sale of shares in public companies, delisting, squeeze-outs and buy-backs. Works for issuers, financial institutions, sellers and investors. Also advises on M&A transactions, supporting buyers, sellers and management of acquired companies.

Represents clients in proceedings before the Financial Supervision Authority, the Warsaw Stock Exchange board, and the National Depository for Securities. Advises on admission of financial instruments to public trading and their dematerialization.

Supports clients in significant corporate matters, including reorganization processes and the structuring and implementation of incentive programs. Attends meetings of corporate bodies. Serves as chairman of general meetings of public companies. Advises on the implementation of disclosure obligations.

Michał Wieliński

Experience

Latest projects

  • Advised Pure Biologics on the acquisition of US-based Dystrogen Gene Therapies from the private capital fund BioFund Capital Management LLC and JD Copilot LLC through a share exchange, the conversion into shares of debt owed to private investment firm ACRX Investments Limited, and a public offering of shares, with an aggregate issue price of PLN 213.5 million
  • Advised the founders of Clicktrans, a leading European online transport platform, on the sale of a 70% stake to private equity fund Spire Capital Partners, with the founders retaining significant minority stakes
  • Advised Creotech Instruments, a WSE-listed company, on a public offering of newly issued Series M shares conducted through an accelerated bookbuilding process (ABB), valued at PLN 481 million, and their admission to trading on the WSE
  • Advised WSE-listed technology company cyber_Folks on the sale of a 19.53% stake in Vercom, a global CPaaS provider, through an accelerated bookbuilding process for PLN 520.8 million, while remaining Vercom’s largest shareholder
  • Advised Creotech Instruments on the spin-off of its quantum business and the WSE listing of Creotech Quantum, with an equity value of approximately PLN 535.6 million
  • Show more
  • Advised MEWO S.A. and its shareholders on the PLN 62.5 million investment by Vinci, a fund within the Bank Gospodarstwa Krajowego group
  • Advised a public company, cyber_Folks, on the acquisition of the French company PrestaShop for approximately EUR 53 million through SPV cyber_Pixel and the contribution of Polish technology companies Sylius and BitBag thereto
  • Advised Cognor Holding on a PLN 300 million secondary public offering conducted through an accelerated bookbuilding (ABB) process, comprising the sale of existing shares by PS Holdco and newly issued shares
  • Advised cyber_Folks on a non-prospectus public offering of series E shares issued through an accelerated bookbuilding (ABB) process, with a value exceeding PLN 200 million
  • Advised Dino Polska on a 1:10 share split and the admission of the shares to trading on the Warsaw Stock Exchange
  • Show more
  • Advised Lithuanian shareholders on the sale of approximately 12.08% of shares in Vercom S.A. through an accelerated bookbuilding (ABB) process, with a value of nearly PLN 300 million
  • Advised cyber_Folks S.A. on the acquisition of a 49.9% stake in listed company Shoper S.A., a SaaS e-commerce platform provider, from private equity fund Value4Capital and other shareholders for approximately PLN 547 million
  • Advised Sescom and its major shareholders on a PLN 104 million sale of a majority stake to Enterprise Investors
  • Advised in the process of the delisting of Sescom
  • Advised Creotech Instruments on a non-brokered public offering conducted under an accelerated bookbuilding procedure (ABB) worth approx. PLN 60 million
  • Show more
  • Advised DataWalk in the preparation and execution of a public offering of shares issued within the Company’s authorized capital, conducted via an accelerated bookbuilding process (ABB)
  • Advised Cavatina Holding in an IPO transaction with a value of approx. PLN 187 million
  • Advised LUX MED in the acquisition of Swissmed Centrum Zdrowia with a value of approx. PLN 60 million
  • Advised Wentworthtech and Savtec in the sale of a majority stake in Suwara with a value of approx. PLN 100 million
  • Advised Elemental Holding in the compulsory buyout process of Elemental Asia
  • Show more
  • Advised Vercom in an IPO transaction with a value of approx. PLN 225 million
  • Advised LUX MED in the process of delisting Swissmed Centrum Zdrowia
  • Advised Erbud in a share buyback transaction
  • Advised DataWalk on its public offering of shares (ABB) with a value of approx. PLN 40 million
  • Advised Vercom in its acquisition of MailerLite with a value of approx. PLN 400 million
  • Show more
  • Advised Caspar Asset Management in the process of transferring its stock listing from the NewConnect market to the main floor of the Warsaw Stock Exchange
  • Advised Pure Biologics and shareholders in a public offering, a share lending transaction and a share sale at ABB with a value of approx. PLN 30 million
  • Advised Urteste on its public offering and in the process of transferring its stock listing from the NewConnect market to the main floor of the Warsaw Stock Exchange
  • Advised Pure Biologics on a PLN 12 million financing transaction with a new investor, ACRX Investments
  • Advised Urteste in its IPO and debut on the NewConnect market
  • Show more
  • Advised Raya Holding in its acquisition of a significant stake in Makarony Polskie
  • Advised Comperia.pl in a share buyback transaction

Education and achievements

  • Legal studies at the Faculty of Law and Administration of Adam Mickiewicz University in Poznań; Studies in international relations (international business and world economy at Adam Mickiewicz University in Poznań (2011)
  • British Law School organized by the British Law Centre (2012), study at Universiteit Gent in Belgium (Erasmus program, 2014)

Awards

Academic publications

News
& Insights

03.09.2026

GESSEL advised cyber_Folks and Shoper on merger creating a near USD 1 billion listed technology group

GESSEL acted as joint legal counsel to cyber_Folks S.A., a European leader in e-commerce technology, and Shoper S.A., Poland’s most frequently chosen online store platfo...

Case studies
GESSEL advised cyber_Folks and Shoper on merger creating a near USD 1 billion listed technology group

05.08.2026

GESSEL advised Pure Biologics on a multi-stage transaction comprising a share exchange offer, debt-to-equity conversion and public share offering

GESSEL advised Pure Biologics S.A., a biopharmaceutical company listed on the Warsaw Stock Exchange, on a complex, multi-stage and multi-jurisdictional transaction combi...

Case studies
GESSEL advised Pure Biologics on a multi-stage transaction comprising a share exchange offer, debt-to-equity conversion and public share offering

29.07.2026

GESSEL advised the founders of Clicktrans on the sale of a majority stake to Spire Capital

GESSEL advised Agnieszka Korzeniewska and Michał Brzeziński, the founders of Clicktrans sp. z o.o., one of Europe's largest online marketplaces connecting customers with...

Case studies
GESSEL advised the founders of Clicktrans on the sale of a majority stake to Spire Capital

14.07.2026

GESSEL advised Creotech Instruments on a PLN 481 million public offering

GESSEL advised Creotech Instruments S.A., a Warsaw Stock Exchange listed space technology company, in connection with its public offering of 650,000 Series M shares cond...

Case studies
GESSEL advised Creotech Instruments on a PLN 481 million public offering
Show more